US Broker Ratings

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with 24% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to capture the attention of investors with its robust standing in the biotechnology sector. With a market capitalization of nearly..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Riding on a 92.10% Revenue Growth Wave

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, is capturing investor attention with its impressive revenue growth of 92.10%. With a market..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Potential 22% Upside with Strong Buy Ratings

Krystal Biotech, Inc. (NASDAQ: KRYS), a dynamic player in the biotechnology sector, has been making waves with its pioneering genetic medicine solutions targeting high unmet medical..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring A 29% Upside Potential for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in South Jordan, Utah,..

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a 28% Upside with Strong Analyst Confidence

Royalty Pharma plc (NASDAQ: RPRX), a unique player in the healthcare sector, presents a compelling investment opportunity with a potential upside of 28.42% based on current..

CVS Health Corporation (CVS): Investor Outlook on a Healthcare Powerhouse with a Promising 8.88% Upside

CVS Health Corporation (NYSE: CVS) stands as a stalwart in the healthcare sector, particularly in the expansive domain of healthcare plans. With its roots firmly planted..

Integer Holdings Corporation (ITGR) Stock Analysis: A 38.79% Upside Potential in the Healthcare Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical devices industry, presents an intriguing investment opportunity with a notable upside potential. With a market..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with a 32.50% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector, capturing investor attention with its remarkable revenue growth and significant potential upside. With a..

Nuvalent, Inc. (NUVL) Stock Analysis: Unlocking a 43% Potential Upside with Promising Cancer Therapies

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is making waves in the healthcare sector with its innovative approach to cancer treatment...

DexCom, Inc. (DXCM) Investor Outlook: Analyzing the 50.77% Potential Upside in the Continuous Glucose Monitoring Market

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector, particularly within the medical devices industry, has captured the attention of investors with its promising growth..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unpacking a 23.53% Potential Upside in the Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX), a pioneering company in the medical devices industry, has captured investor attention with its innovative solutions for organ transplant therapy. With..

Vaxcyte, Inc. (PCVX) Stock Report: Exploring a Potential 212.93% Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage biotechnology company, is making significant waves in the healthcare sector with its innovative approach to vaccine development. Specializing in conjugate..

Waystar Holding Corp. (WAY) Stock Analysis: A 32.59% Potential Upside Beckons Investors

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, is currently attracting significant attention from investors due to its promising growth potential..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring a 28% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a stalwart in the biotechnology sector, has been making waves in the healthcare industry with its innovative therapies. With a market..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 47% Upside Potential Beckons Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology industry, presents a compelling case for investors seeking growth opportunities in the healthcare sector. Headquartered..

ICON plc (ICLR) Stock Analysis: An Investor’s Guide to Understanding Its 31.67% Upside Potential

Investors looking for exposure in the healthcare sector, particularly in diagnostics and research, may find ICON plc (NASDAQ: ICLR) an intriguing opportunity. Headquartered in Dublin, Ireland,..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Landscape with Promising Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) operates at the intersection of healthcare and technology, a sector that continues to attract investor interest due to its transformative potential...

Akero Therapeutics (AKRO) Stock Analysis: A Promising Biotech with 61.92% Potential Upside

For investors with a keen interest in the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents an intriguing opportunity. Specializing in the development of treatments for..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Unveiling a 13.58% Potential Upside with Robust Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing significant attention from investors with its strong revenue growth and promising market..

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Unveiling Potential with a 24.59% Upside

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, is capturing attention with its promising portfolio in RNA-targeted therapeutics and gene therapies. As a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds